CODX
Co-Diagnostics Inc (CODX)
Healthcare • NASDAQ • $3.57+10.53%
- Symbol
- CODX
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $3.57
- Daily Change
- +10.53%
- Market Cap
- $12.42M
- Trailing P/E
- N/A
- Forward P/E
- -0.28
- 52W High
- $46.50
- 52W Low
- $1.26
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- N/A
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes;…
Company websiteResearch CODX on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.